Quantitative In Vivo Optical Imaging of Vascular Response to Hind Limb Ischemia
Quantitative In Vivo Optical Imaging of Vascular Response to Hind Limb Ischemia
批准号:
8386295
负责人:
Craig Lewis Duvall
金额:
$18.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-07-31
关键词:
AdultAffectAge-YearsAlgorithmsAmericanAnesthesia proceduresAnimal ModelAnimalsArteriesBiologicalBiological MarkersBiological ModelsBloodBlood CirculationBlood VesselsBlood capillariesBlood flowCell TherapyClinicalContrast MediaDataData SetDevelopmentDimensionsDoseGoalsGoldGrantGrowth FactorHindlimbHourHypoxiaImageImaging TechniquesImaging technologyInjuryIschemiaLifeLimb structureLower ExtremityMapsMeasurementMeasuresMethodologyMethodsMicroscopeMicroscopyModelingMorphologyMusMuscleOptical Coherence TomographyOpticsOutcomePatientsPeripheralPeripheral arterial diseasePhysiologicalPlayPreclinical TestingProceduresPubMedPublicationsQuality of lifeRecoveryRelative (related person)ResearchResearch PersonnelResolutionRoleStructureSystemTechniquesTechnologyTestingThigh structureThree-Dimensional ImageTimeTissuesValidationVascular Endothelial Growth FactorsWorkloadangiogenesiscapillarycohortcostdesignfield studyfootgene therapyimage processingimaging probein vivoindexinginnovationinstrumentmanmethod developmentneovascularizationnovelnovel strategiesnovel therapeuticsoptical imagingpre-clinicalpreclinical studyresponserestorationtechnique developmenttherapeutic angiogenesistherapeutic developmenttissue oxygenationtooltreatment effecttreatment strategy
中文摘要
描述(由申请人提供):外周动脉疾病(PAD)估计影响多达20%的65岁以上美国成年人,导致下肢功能下降和整体生活质量下降。治疗性血管生成,即刺激新血管取代功能失调的病变动脉的功能,是一种有希望的、相对较新的方法,可以恢复外周循环,提高PAD患者的生活质量。小鼠后肢缺血模型是一种常用的临床前系统,用于测试新的治疗性血管生成策略,包括生长因子输送、基因治疗和细胞治疗。后肢缺血模型也为研究体内新生血管形成的生物学机制提供了一个明确的、已有特征的平台。然而,由于缺乏提供的定量数据、用户主观性、空间分辨率不足、缺乏纵向体内成像能力以及需要获取多组小鼠来分析血管结构和功能等缺点,目前缺乏表征该模型系统血管生成反应的分析技术。当前提案的中心目标是开发一种光学活体成像技术,可用于获取血管形态、血流和氧合的共注册3D图像数据。所获得的定量数据集将显著提高在单一剂量麻醉下可从单个小鼠获得的互补结构-功能数据的数量。此外,临床前和基础研究的吞吐量应该加快,实验成本应该降低,因为可以在单个小鼠中进行重复成像。本文提出了两个目标,即(1)技术开发和(2)相对于传统“金标准”技术的技术验证。所提出的技术有潜力为血管生成研究人员提供创新的新工具,并加速新的治疗策略的发展,以治疗重要的PAD临床问题。
英文摘要
DESCRIPTION (provided by applicant): Peripheral arterial disease (PAD) is estimated to affect as many as 20% American adults over 65 years of age and results decreased lower extremity function and overall quality of life. Therapeutic angiogenesis, stimulation of new blood vessels to replace the function of dysfunctional, diseased arteries, represents a promising, relatively new approach that could restore peripheral circulation and quality of life for PAD patients. The mouse hind limb ischemia model is a commonly used preclinical system for testing new therapeutic angiogenesis strategies including growth factor delivery, gene therapy, and cell therapy. The hind limb ischemia model also provides a well-defined and previously-characterized platform for studying the biological mechanisms of neovascularization in vivo. However, analytical techniques for characterization of the angiogenic response in this model system are at present lacking due to one or more shortcomings including lack of quantitative data provided, user subjectivity, inadequate spatial resolution, lack of longitudinal in vivo imaging capability, and the requirement for procuring multiple sets of mice for analysis of both vessel structure and function. The central goal of the current proposal is to develop an optical, intravital imaging technique that can be used to acquire co-registered, 3D image data on vessel morphology, blood flow, and oxygenation. The acquired quantitative data sets will provide a significant improvement in the amount of complementary structure-function data that can be taken from a single mouse under a single dose of anesthesia. Furthermore, throughput of preclinical and basic studies should be accelerated and experimental costs decreased because repeated imaging can be carried out in a single mouse. Two aims are proposed that span (1) technique development and (2) technique validation relative to traditional "gold standard" techniques. The proposed technique has the potential to provide innovative, new tools of high impact to angiogenesis researchers and to accelerate development of new therapeutic strategies for treatment of significant clinical problem of PAD.
PUBLIC HEALTH RELEVANCE: Small animal models of peripheral limb ischemia play an integral role in understanding the basic mechanisms of neovascularization of ischemic tissues and preclinical testing of pro-angiogenic therapies. However, a significant shortcoming exists in the availability of quantitative, high resolution methodologies for longitudinal assessment of blood vessel morphology and function within living animals. Here, we propose to develop a novel optical imaging approach capable of simultaneous assessment of vascular morphology, blood flow, and oxygenation in living mice without the need for exogenous contrast agent administration. This technique will enable more robust assessments of vascular structure/function and is anticipated to accelerate new discoveries on the mechanistic control of angiogenesis and the development of therapeutic revascularization technologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
-
批准号:10623705
-
项目类别:
-
资助金额:$66.79万
-
财政年份:2023
-
负责人:Craig Lewis Duvall
-
依托单位:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
-
批准号:10539405
-
项目类别:
-
资助金额:$62.21万
-
财政年份:2022
-
负责人:Craig Lewis Duvall
-
依托单位:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
-
批准号:10688080
-
项目类别:
-
资助金额:$54.32万
-
财政年份:2022
-
负责人:Craig Lewis Duvall
-
依托单位:
Albumin hitchhiking siRNAs for gene targeting in aged brain
-
批准号:10611521
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2022
-
负责人:Craig Lewis Duvall
-
依托单位:
Albumin hitchhiking siRNAs for gene targeting in aged brain
-
批准号:10467737
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2022
-
负责人:Craig Lewis Duvall
-
依托单位:
Albumin Binding siRNAs for Systemic Treatment of Multi-Joint Osteoarthritis
-
批准号:10358582
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2021
-
负责人:Craig Lewis Duvall
-
依托单位:
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound Healing
-
批准号:10446305
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2021
-
负责人:Craig Lewis Duvall
-
依托单位:
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound Healing
-
批准号:10245000
-
项目类别:
-
资助金额:$47.52万
-
财政年份:2019
-
负责人:Craig Lewis Duvall
-
依托单位:
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound Healing
-
批准号:10668940
-
项目类别:
-
资助金额:$47.54万
-
财政年份:2019
-
负责人:Craig Lewis Duvall
-
依托单位:
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound Healing
-
批准号:10005338
-
项目类别:
-
资助金额:$47.4万
-
财政年份:2019
-
负责人:Craig Lewis Duvall
-
依托单位:
MK2 Inhibitory Nanoplexes to Enhance Long-Term Vascular Graft Patency
-
批准号:9463239
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2016
-
负责人:Craig Lewis Duvall
-
依托单位:
Bioresorbable Polythioketal Urethane Wound Dressings
-
批准号:10734630
-
项目类别:
-
资助金额:$58.35万
-
财政年份:2014
-
负责人:Craig Lewis Duvall
-
依托单位:
Substrate Mediated siRNA Delivery from Scaffolds to Promote Wound Repair
-
批准号:8801983
-
项目类别:
-
资助金额:$34.42万
-
财政年份:2014
-
负责人:Craig Lewis Duvall
-
依托单位:
Quantitative In Vivo Optical Imaging of Vascular Response to Hind Limb Ischemia
-
批准号:8520387
-
项目类别:
-
资助金额:$21.21万
-
财政年份:2012
-
负责人:Craig Lewis Duvall
-
依托单位:
Injectable Scaffold for Efficient, Tunable siRNA Delivery to Skin Wounds
-
批准号:8305480
-
项目类别:
-
资助金额:$22.82万
-
财政年份:2011
-
负责人:Craig Lewis Duvall
-
依托单位:
Smart Polymer Based MK2 Inhibitor to Suppress Vascular Graft Intimal Hyperplasia
-
批准号:8179533
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2011
-
负责人:Craig Lewis Duvall
-
依托单位:
Injectable Scaffold for Efficient, Tunable siRNA Delivery to Skin Wounds
-
批准号:8192011
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2011
-
负责人:Craig Lewis Duvall
-
依托单位:
Smart Polymer Based MK2 Inhibitor to Suppress Vascular Graft Intimal Hyperplasia
-
批准号:8309336
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2011
-
负责人:Craig Lewis Duvall
-
依托单位:
Intracellular Peptide Delivery for Targeted Destruction of Cancer
-
批准号:7485474
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2008
-
负责人:Craig Lewis Duvall
-
依托单位:
Intracellular Peptide Delivery for Targeted Destruction of Cancer
-
批准号:7646281
-
项目类别:
-
资助金额:$3.6万
-
财政年份:2008
-
负责人:Craig Lewis Duvall
-
依托单位:
海外基金